Skip Navigation LinksDDAP > Announcements

ANNOUNCEMENTS

   You are viewing a page that contains frequently added announcements.  Subscribe to our RSS feed to receive announcements as they become available. 
  
  
Body
2/14/2017 7:37 AM
  

​We are pleased to inform you that the Pennsylvania Liquor Control Board’s (PLCB) Office of Regulatory Affairs, Bureau of Alcohol Education 2017-2019 grant process is officially open. Funding is available to colleges, universities, municipalities, schools, and community organizations throughout the Commonwealth to help reduce and eliminate underage and dangerous use of alcohol. The maximum award is $40,000 for the two years, with a maximum of $20,000 per year. Only one grant application per organization, school, municipality, or institution of higher education may be submitted. The deadline for submission is 4:00 PM, Friday, March 31, 2017.
 
The 2017-2019 grant application is available online at www.lcb.pa.gov. Click on Education, then Programs. Instructions and frequently asked questions can also be found there. 
 
If you would like additional information or have any questions, please feel free to contact the Bureau of Alcohol Education at 717-772-1432 or RA-LBAEGRANT@pa.gov.

1/18/2017 9:22 AM
  

Registration is now open for the 2017 Council on Compulsive Gambling of Pennsylvania (CCGP) Annual Statewide Conferences. The March 9 conference will be held in Trevose, PA while the March 16 conference will be held in Pittsburgh, PA. A limited number of scholarships are available for both conferences. Please contact Josh Ercole at josh@pacouncil.com for more information regarding the scholarships. Conference details can be found at CCGP’s website www.pacouncil.com.

1/18/2017 9:19 AM
  

Please find a link to the PA Department of Health’s Hepatitis C webpage which includes the PA Hepatitis C Epidemiologic Profile 2003-2014.

 

Hepatitis C Epidemiologic Profile in Pennsylvania

 

1/13/2017 9:46 AM
  

Grant Applications are currently being accepted.  Applications are due 3/15.  More information can be found via the links below.

 
 
12/22/2016 8:44 AM
  

​The Pennsylvania Department of Drug and Alcohol Programs’ FY 2017 Annual Synar Report is currently available for review on the agency’s website:  http://www.ddap.pa.gov/Pages/Annual-Reports.aspx .  This report is submitted to SAMHSA as a requirement of the Substance Abuse Block Grant and provides information about initiatives aimed at decreasing youth access to tobacco. 

In addition to the DDAP website, this report along with the full SAPT Block Grant Application, is available on WebBGAS.  To access the block grant reports, log in as "citizenpa" and use "citizen" as your password.  Comments can be made at:  http://www.ddap.pa.gov/Pages/Contact_Request_Form.aspx

11/22/2016 8:54 AM
  

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has been absent a data solution to gather and report Treatment Episode Data System (TEDS) information to the Substance Abuse and Mental Health Services Administration (SAMSHA) since September of 2015.  DDAP also recognized the need to secure a system to replace its legacy prevention data collection system. DDAP is excited to announce that the agency, along with its partners in the Department of Health, Bureau of Informatics and Information Technology and the Department of Administration, Office of Information Technology, has completed its evaluation of data systems and awarded the new contract to FEi Systems, Inc. to provide their proven Web Infrastructure for Treatment Services (WITS) solution.  FEi is a leading health IT, services, and analysis organization, specializing in healthcare solutions for federal, state, and local governments. For the past decade, FEi has been at the forefront of the industry in its primary areas of expertise—behavioral health data systems and IT solutions, long term services and supports software solutions, and health IT for federal and state clients.

                                                                                                                                                                                
The data system selected, WITS, is a web-based application that has been in production since 2003, when the pilot customers Iowa, Alaska and Salt Lake County, Utah, began using the system to collect clinical and TEDS data for reporting. Since that time, the solution is currently in use by 30 states and counties for a wide variety of clinical, contract, billing, and case management services.  DDAP will join the WITS User Group (WUG) that will enable coordination, collaboration and cost sharing among the other states using the WITS solution.  The WITS solution will provide SCAs, Providers  and DDAP with a single integrated system to collect Treatment and Prevention data that satisfies mandatory government reporting requirements for the planning, administration, and monitoring of Behavioral Health Treatment Programs, Prevention Programs, and Federal Grant Management programs.
 
The implementation and rollout of the WITS data system will be clearly communicated with all stakeholders.  DDAP is working with FEi Systems to develop a timeline for implementation and we will provide updates as soon as they are available.
 
Thank you all for the outstanding services provided to our clients!
10/26/2016 2:30 PM
  

​DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS ANNOUNCES:


FREE DOWNLOADABLE MEDIA LITERACY CURRICULA
(MIDDLE AND HIGH SCHOOL)

The Department of Drug and Alcohol Programs is pleased to announce that it is making available free, downloadable educational curricula to prevention providers and educators for the purpose of teaching digital and media literacy to middle and high-school students.
 
The “Media Straight Up! Critical Thinking Skills for Pennsylvania’s Youth” (middle school level) and “Pushing Back: Responding to Representation of Drugs and Alcohol in Popular Culture” (high school level) are curricula that provide specific instructional strategies for raising young people’s awareness and critical thinking skills in responding to mass and social media messages that depict alcohol, tobacco, prescription and illegal drug use. Digital and media literacy skills help students to evaluate the quality and accuracy of what they see, hear and read. They help them recognize how and why media messages appeal to their audience, sharpening awareness of unstated but implied messages. 
 
These media literacy curricula are a resource for any prevention specialist or educator to teach youth about the important skills of digital and media literacy which can contribute to a young person’s ability to understand how media messages affect their perceptions of drugs and alcohol, and may influence the choices they make. Prevention specialists, teachers, school counselors, and community leaders can each play a role in promoting critical thinking to our students about the unhealthy messages they hear and see daily throughout today’s media.
 
To download and/or learn more about these valuable and free resources, please visit: http://www.ddap.pa.gov/Prevention/Pages/Digital%20Media.aspx
8/22/2016 9:47 AM
  

​The Pennsylvania Gaming Control Board has launched a multi-faceted public service campaign to warn youth and parents about the dangers of attempting to gamble at a PA casino when underage.  Feel free to disseminate this information on your website, social media sites, etc. 

The campaign is titled “What’s Really at Stake” and is designed to raise awareness among youth that it is illegal to gain access to a casino floor in Pennsylvania under the age of 21, convey the numerous consequences of underage gambling, and demonstrate the link between underage gambling and other negative behaviors.
Additionally, the campaign provides messages to parents and friends who all too often facilitate gambling by an underager.
The campaign elements for disseminating its message include:
• A website, www.whatsreallyatstake.com
• Social media posts on Facebook (www.facebook.com/WhatsReallyAtStake) and Twitter (www.twitter/WhatsAtStakePA)
• YouTube Videos (https://www.youtube.com/watch?v=2JYZtZAN0aU)
• Posters within PA casinos
 
All funding for the What’s Really at Stake campaign is derived from confiscated winnings of voluntary or involuntary excluded patrons who illegally entered a Pennsylvania casino, gained winnings, and were caught in the facility.
8/5/2016 12:21 PM
  

The Department of Drug and Alcohol Programs (DDAP) has released an innovative tool to identify available treatment beds for individuals in residential treatment programs.  For more information or to register, you can visit the PA Open Beds page on our website  or email RA-DAOPENBEDS@pa.gov  or call Dan Miller at 717-736-7466

 
8/5/2016 12:20 PM
  

DDAP wishes to make our stakeholders and the general public aware of two discount opportunities for the individual purchase of naloxone with a prescription or through the use of the Pennsylvania Physician General’s Standing Order:
 
•    Kaleo, the manufacturer of the “Evzio” naloxone auto-injector has announced that they will minimize the out-of-pocket cost to patients and their family members and caregivers by providing commercially-insured patients filing a prescription for EVZIO with an out-of-pocket cost of less than $20 or, in most cases, $0, even if their commercial insurance plan does not cover EVZIO.  This reduced price is through a pharmacy discount.  Additional information about this reduced price can be found at:
 
•   AdaptPharma, the manufacturer of Narcan Nasal Spray, has partnered with CVS Pharmacy to offer individuals without insurance a $35 discount coupon available through the local CVS pharmacy.
 
DDAP requests that this information be shared at large so that individuals are made aware of these opportunities for obtaining naloxone at a reduced cost.
 
(Note:  DDAP requests that pharmaceutical companies or pharmacy discount programs notify the Department of any additional price discounts as they become available so that they can be added to this announcement.)
 
8/4/2016 1:42 PM
  

The Department of Drug and Alcohol Programs (DDAP) is concerned about the rise in hepatitis C cases in Pennsylvania (PA), particularly among persons who inject drugs (IDU).  The Centers for Disease Control and Prevention recommends hepatitis C virus (HCV) testing for those who currently inject any type of drug (Opioids, Methamphetamine, Cocaine, etc.) or have injected drugs in the past, including those who injected once or a few times many years ago.  PA has experienced a dramatic increase in hepatitis C infections in individuals with injection opioid and/or heroin addiction who are 18 to 35 years of age.  DDAP recommends that all licensed drug and alcohol addiction treatment facilities perform a risk assessment for HCV and refer to medical or community based providers for necessary screening/testing as appropriate.
 
Because many individuals you serve are at high risk for hepatitis C, you play an important role in combating this public health issue.  If you have current practices that you believe are effective in combating this disease, we would appreciate you sharing these with us so we can promote them across the field.  Please send this information to Justin White at
justinwhit@pa.gov.
 
Through improved identification and treatment of individuals with hepatitis C, we can begin to reduce the spread of this disease.  Please remember to obtain consumer consent and maintain confidentiality when sharing test results with the consumers’ primary care physicians or other physical health specialists involved in hepatitis treatment.  In some cases, you may be able to utilize a Qualified Service Organization Agreement (QSOA) to permit the exchange of patient identifying information.  If you have questions about when this is possible, please contact our Division of Licensing Director, Treldon Johnson, at
trejohnson@pa.gov.
 
For more information regarding hepatitis C testing of IDU clientele, please contact:
 
Charles Howsare, MD, MPH
Viral Hepatitis Prevention Coordinator
PA Department of Health
717-787-3350
chowsare@pa.gov
 
Thank you for your critical assistance in controlling hepatitis C in PA.
 
Contact Person:  Justin White
                                717-736-7474
6/24/2016 8:52 AM
  

​DDAP is currently working with Department of Human Services, Division of Facilities and Property Management to identify locations in the Commonwealth that our Drug and Alcohol provider network might be able to  leverage for expansion of services.  These locations may be more affordable and require less effort than building a new facility. Current list of available locations is attached. If a provider is interested in seeing the properties available, or would like more information regarding this,  please contact Jodi Skiles at joskiles@pa.gov or 717-736-7454.​

6/24/2016 8:50 AM
  

​Join Us for the 2016 Communities Talk: Town Hall Meetings to Prevent Underage Drinking


The Substance Abuse and Mental Health Services Administration (SAMHSA) invites you to join in the 2016 Communities Talk: Town Hall Meetings to Prevent Underage Drinking initiative. SAMHSA has sponsored Communities Talk: Town Hall Meetings every two years since 2006 to raise awareness about underage and harmful drinking and to mobilize communities across the country to take actions that we know can and do save lives.

Help continue the downward trend in underage drinking and alcohol abuse by planning one or more Communities Talk events.  A limited number of $500 stipends are available to support your event, which can take a range of forms—from small community gatherings to larger events on a college campus.  Stipends are being distributed on a first-come, first-served basis.


Please contact info@stopalcoholabuse.net with the name of your organization, contact name, e-mail address, and phone number by Friday, June 30.  We will expedite your invitation to register once we receive your request.


Visit the Communities Talk: Town Hall Meetings website and check out the tips and resources and success stories for creative ideas on how to get started.  Download this flyer to learn more.
If you have questions or comments, email us at info@stopalcoholabuse.net.​

6/24/2016 8:49 AM
  

Please be aware of the following communication/commitment from Kaleo Pharmaceutical for individual persons obtaining naloxone via their pharmacy:

Any commercially insured person with a prescription can now quickly obtain EVZIO with an out-of-pocket cost of, in most cases, $0, even if their insurance does not cover EVZIO. To facilitate this, Kaleo Pharmaceutical has a toll free number, 877-4-EVZIO-EZ, that patients, physicians, or pharmacists can use to get immediate assistance to fill this potentially life-saving prescription.

Feel free to share this information with others.

6/24/2016 8:49 AM
  

​DDAP and the PA Department of Health have been working closely with the PA Medical Society (PAMED) to support their efforts to create a free Continuing Medical Education (CME) related to “Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know.”   This CME program is divided into four modules and covers a variety of tools and resources for prescribers and dispensers to better address opioid addiction. 

  1. Opioid Prescribing Guidelines
  2. Naloxone Prescribing
  3. Referral to Treatment   
  4. In process: Prescription Drug Monitoring Program called the ACHIEVING BETTER CARE BY MONITORING ALL PRESCRIPTIONS PROGRAM or (ABC-MAP) 

PAMED has decided to make ALL their opioid CME’s available at no-cost until the end of the 2016 calendar year.  Given the extent of the opioid crisis and the urgent need for physicians and other providers to get up to speed on opioid prescribing guidelines, naloxone, referrals to treatment, and the ABC-MAP Program, PAMED wanted to promote this CME to ALL members of the healthcare team that need it.  With that in mind, your group may want to consider doing the same if you are currently charging for the series.  The link to PAMED’s CME that is includes the test and certificate for CME credits is:
https://www.pamedsoc.org/learn-lead/topics/medications-pain-management-opioids/OpioidsCrisisCME

Also, PAMED is going to be developing a 5th module on “Alternative Treatment of Pain” that will highlight non-opioid medication, OT/PT, complementary medicine, and behavior health approaches to managing chronic, non-cancer pain. 

6/22/2016 6:42 AM
  

​​DDAP is currently working with Department of Human Services, Division of Facilities and Property Management to identify locations in the Commonwealth that our Drug and Alcohol provider network might be able to  leverage for expansion of services.  These locations may be more affordable and require less effort than building a new facility. Current list of available locations is attached. If a provider is interested in seeing the properties available, or would like more information regarding this,  please contact Jodi Skiles at joskiles@pa.gov or 717-736-7454.

6/22/2016 6:38 AM
  

​Please be aware of the following communication/commitment from Kaleo Pharmaceutical for individual persons obtaining naloxone via their pharmacy:

Any commercially insured person with a prescription can now quickly obtain EVZIO with an out-of-pocket cost of, in most cases, $0, even if their insurance does not cover EVZIO. To facilitate this, Kaleo Pharmaceutical has a toll free number, 877-4-EVZIO-EZ, that patients, physicians, or pharmacists can use to get immediate assistance to fill this potentially life-saving prescription.

Feel free to share this information with others.

6/22/2016 6:37 AM
  

​DDAP and the PA Department of Health have been working closely with the PA Medical Society (PAMED) to support their efforts to create a free Continuing Medical Education (CME) related to “Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know.”   This CME program is divided into four modules and covers a variety of tools and resources for prescribers and dispensers to better address opioid addiction. 

  1. Opioid Prescribing Guidelines
  2. Naloxone Prescribing
  3. Referral to Treatment   
  4. In process: Prescription Drug Monitoring Program called the ACHIEVING BETTER CARE BY MONITORING ALL PRESCRIPTIONS PROGRAM or (ABC-MAP) 

PAMED has decided to make ALL their opioid CME’s available at no-cost until the end of the 2016 calendar year.  Given the extent of the opioid crisis and the urgent need for physicians and other providers to get up to speed on opioid prescribing guidelines, naloxone, referrals to treatment, and the ABC-MAP Program, PAMED wanted to promote this CME to ALL members of the healthcare team that need it.  With that in mind, your group may want to consider doing the same if you are currently charging for the series.  The link to PAMED’s CME that is includes the test and certificate for CME credits is:
https://www.pamedsoc.org/learn-lead/topics/medications-pain-management-opioids/OpioidsCrisisCME

Also, PAMED is going to be developing a 5th module on “Alternative Treatment of Pain” that will highlight non-opioid medication, OT/PT, complementary medicine, and behavior health approaches to managing chronic, non-cancer pain. 

6/10/2016 11:48 AM
  

​The Department of Drug and Alcohol Programs (DDAP) has been made aware of concerns regarding the rates established between the Single County Authorities (SCAs) and the non-hospital residential detoxification and rehabilitation treatment facilities. To address this issue, DDAP has convened a comprehensive workgroup to identify solutions for the longer term relative to the process and instruments utilized to determine per diem rates. However, for more immediate resolution concerning rates being negotiated for State Fiscal Year 2016/17, DDAP is initiating a two-phase appeals process that allows providers to appeal to the SCA rate setting authority, and failing a satisfactory outcome, the ability to bring appeal to DDAP. This process also allows the SCAs, should negotiations fail to bring about satisfactory result, the ability to appeal to DDAP for final resolution. Attached to this correspondence is a matrix outlining the process for appeal to be followed by both treatment providers and SCAs, as well as the minimum documentation to be submitted with an appeal. Questions that arise in regards to the appeals process may be directed to the resource account established for this process and denoted on the attachment.

6/2/2016 9:52 AM
  

​The Department of Drug and Alcohol Programs (DDAP), along with the PA Department of Health, has created various overdose prevention and response resources including brochures, flyers, posters, etc.  These resources are now available for download and reproduction under the Publications page of DDAP’s Document Library.

5/16/2016 7:23 AM
  

The PBPS support line is open Monday through Friday from 9 AM to 5 PM at 1-888-600-4777.  It can also be reached via email at support@mosaixsoftware.com  If you have any comments you would like to pass along regarding your support experience, please note the date and time you contacted the PBPS help desk along with details of your experience and email them to DDAP at RA-DAWORKFLOW@PA.GOV

5/4/2016 1:39 PM
  

​The 2015 PAYS County Reports have been posted on the PAYS website and are available for download at www.pays.pa.gov.  Select “2015” in the last paragraph on the page and then select “2015 County Reports”. 

4/26/2016 6:57 AM
  

​Marijuana and Cannabinoids: A Neuroscience Research Summit was convened by the National Institutes of Health, which focused on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system were discussed. The goal of this summit was to ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana.


This summit was recorded and the archived video recordings of the summit are now available - http://apps1.seiservices.com/nih/mj/2016/VideoCast.aspx.

4/5/2016 2:22 PM
  

​On April 5, 2016, the Pennsylvania Department of Health in collaboration with AdaptPharma, announced details about a program in which every public secondary school in the state can receive 2 free doses of naloxone, the opioid overdose reversal medication.  Just as school districts would want to have other first aid resources on hand in their buildings, they are also encouraged to access this free supply of naloxone.  Such efforts are supported and encouraged by Governor Wolf and the Secretaries of the Departments of Education, Health, and Drug and Alcohol Programs because overdose can occur anywhere, anytime, in any socio-economic or age group.  Unfortunately, there have been reports of overdoses occurring at school.

Information about the program, including the application to access the medication is available at:  (http://www.health.pa.gov/My%20Health/School%20Health/Pages/Narcan-Program-in-Schools.aspx#.VwO5CKPD_X4).   The link to the right of this webpage includes the actual application as well as guidance on school policy development and standing orders for school districts.
 
Any questions related to this program or general questions regarding Narcan (naloxone) administration in schools must be sent to RA-DHNARCAN-SCHOOLS@pa.gov.
3/8/2016 6:58 AM
  
As you know, smoking increases the risk for a variety of very serious health problems. People who stop smoking greatly reduce their risk for disease and early death.  Although the health benefits are greater for people who stop at earlier ages, there are benefits at any age. 
 
The Department of Drug and Alcohol Programs asks that you take 5 minutes to fill out the following survey: https://www.surveymonkey.com/r/DDAPTobaccoCessation.
2/24/2016 2:32 PM
  

​SAMHSA Proposes Major Changes to Federal Substance Abuse Privacy Rule

THE NATIONAL LAW REVIEW (02/09) - Almost thirty years after the last substantive change to the federal regulations governing the confidentiality of alcohol and drug abuse patient records, the Substance Abuse and Mental Health Services Administration (SAMHSA) today published a proposed rule (Proposed Rule) to modernize the regulations at 42 CFR Part 2 (the Part 2 Rule). Read more at http://www.natlawreview.com/article/samhsa-proposes-major-changes-to-federal-substance-abuse-privacy-rule.

Revised Opioid Overdose Toolkit Now Available From SAMHSA
 
SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (01/25) - The Substance Abuse and Mental Health Services Administration (SAMHSA) has released a revised version of the Opioid Overdose Toolkit. This toolkit is designed to educate first responders, physicians, patients, family members, and community members on ways to prevent opioid overdose. Read more at http://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit-Updated-2016/SMA16-4742.

Researchers Offer New Approach to Treating Cocaine Addiction
 
MEDICAL XPRESS (02/10) - In the ongoing fight against drug addiction, researchers from the University of Pennsylvania's School of Nursing and Perelman School of Medicine have discovered a unique application for an FDA-approved drug currently used for obese patients and type 2 diabetics: treatment for cocaine dependence. Read more at http://medicalxpress.com/news/2016-02-approach-cocaine-addiction.html/
 
When Growing Up Hurts: How Parental Addiction Impacts Kids
 
HUFFINGTON POST (02/15) – Who we are speaks louder than what we say. Our facial and body language, the quality of our touch and the emotion and intent emanating from our expressions communicate more to the small child than words ever could. Read more at http://www.huffingtonpost.com/dr-tian-dayton/when-growing-up-hurts-how_b_9220596.html.

 
2/8/2016 6:38 AM
  
  • ​The President of the American Compulsive Gambling Counselor Certification Board has announced that a merger has been agreed upon and will be implemented soon between the American Compulsive Gambling Counselor Certification Board and the International Gambling Counselor Certification Board (ICCB).  This merger will bring about changes such as: NCGC (National Certified Gambling Counselor) I and II certifications are eventually being changed to  ICGC (International Certified Gambling Counselor) I and II certifications.
  • Those who have been Certified Compulsive Gambling Counselors (CCGC) under American Board for a period in excess of one year will be eligible to be grandfathered into the new certification called ICGC-II.  The new Certification will be for a 3 year term rather than the current two.  The cost for grandfathering into the new certification will be $95.  (You will be required to submit a copy of your most recent American Certification, proof of 10 hours of continuing education in problem gambling specific areas and a total of 12 hours in the fields of alcoholism, drug abuse, addiction, psychology or sociology with thee recertification fee.  As part of the fee, you will be listed on the National Council on Problem Gambling website as a certified counselor in your state.)  The National Council on Problem Gambling will be responsible for servicing the certification process. 
  • Anyone presently certified as an Associate Certified Gambling Counselor (ACGC) will be able to apply for ICGC-I  after clinical and supervision hourly requirements have been met (100 hrs. clinical and 4 hours supervision).
  • There will also be an opportunity to qualify as a BACC (Board Approved Clinical Consultant).  This will allow you to provide supervision, as anyone seeking initial certification will be required to be supervised by a BACC.   To learn more about this please visit the International Gambling Counselor Certification Board’s website at www.IGCCB.org.
2/2/2016 7:38 AM
  

​SAMHSA’s Center for the Application for Prevention Technologies has now made several of its self-paced online courses available on their website.  See additional details below.  We strongly encourage SCAs and providers to take advantage of these training opportunities.  All of these courses can be counted toward DDAP’s 12 hour prevention training requirement outlined on Page 4.01.2 of the DDAP Prevention Manual.

Prevention Training Now! Visit the CAPT's new online training platform for practitioners interested in learning more about preventing substance misuse. Explore a range of critical prevention topics -- at your own rate and on your own schedule. Multiple courses are now open for self-enrollment. All courses have been endorsed by the International Certification and Reciprocity Consortium (IC&RC). To access, click on the Prevention Training Now! button on the CAPT homepage: www.samhsa.gov/capt.

Available courses include:

• Introduction to Substance Abuse Prevention
• What is the SPF? An Introduction to SAMHSA's Strategic Prevention Framework
• Go Get It! Finding Existing Data to Inform Your Prevention Efforts
• Focusing on Focus Groups
• Key Informant Interviews
• Involving Youth in Your Substance Abuse Prevention Program
1/13/2016 11:05 AM
  

​To help increase the number of trained clinical providers available to treat problem gambling in Pennsylvania, and to help support counselors in their effort to become nationally certified gambling counselors, the Department of Drug and Alcohol Programs (DDAP) offers monthly clinical supervision conference calls through the Council on Compulsive Gambling of PA (CCGP).  The conference calls are available to those counselors with at least 15 hours of approved gambling specific training and education.  The calls are free and are designed to meet or exceed the requirements for Board Approved Clinical Consultation (BACC) hours as required by the International Gambling Counselor Certification Board (IGCCB).  Calls are held on the first Monday of each month at 12:00 noon EST.  Visit the events section of the CCGP’s website at http://www.pacouncil.com/training/conference-calls/ to learn more about the calls, including registration information.     

1/4/2016 2:39 PM
  

​The Department of Drug and Alcohol Programs has updated the following forms:

  •   Minor Content 
    • Changes to ​DDAP-EFM-1005 - Client Admission
      • Transaction Type -- Selection of "Initial Admission" has been reworded to "Initial Admission to Episode of Care"
      • Referral Source -- Selection of "Family/Friends" has been added back into this dropdown list.  This option was inadvertently removed in an earlier version.
      • Under the "Substance Abuse at Admission" section on page 2, the "Last Used" fields have been reworded to "Date Last Used".
      • Under the "Diagnosis" section, the Secondary Diagnosis and Tertiary Diagnosis fields have been unbolded.
    •     Changes to DDAP-EFM-1002 - Adolescent Placement Summary Sheet and DDAP-EFM-1003 - PCPC Summary Sheet
      • The requirement for a clincian signature has been removed.
      • The supervisor signature is only required until the assessor has met the training and competency requirements.
      • The following changes have been made to the section for providers receiving the referred summary sheet
        • Fields have been added to enter name of individual validating the summary sheet and validation date.
        • The supervisor signature is only required until the validator has met the training and competency requirements.
  • Non-Contenct Changes (i.e., improvements to form fields, layout, etc)
    • DDAP-EFM-1000 - Screening Tool - Part 1 Client Profile
    • DDAP-EFM-1001 - Screening Tool - Part 2 Client Screen
    • DDAP-EFM-1004 - Authorization
    • DDAP-EFM-1006 - Services Rendered

 

The forms are available on our website under the DDAP Document Library, Forms page.

1 - 30Next